BILLS-117hr3537rh.pdf

02:09 Dec 09, 2021 DECEMBER 8, 2021 1ST SESSION H. R. 3537 MAY 25, 2021 2026 later than 4 years days 1965 later than 6 months 42 U.S.C. 284a 5-year later than one year 1986 each of fiscal years September 30, 2026 one year

SESSION H. R. 3537 the ‘‘Accelerating Access the ‘‘Partnership

PO 00000 Frm 00001 PO 00000 Frm 00010 PO 00000 Frm 00017 PO 00000 Frm 00019 PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00002

California Texas Louisiana Florida New York Illinois Pennsylvania Georgia Kansas New Jersey North Carolina Ohio New Jersey the United States Maryland Virginia Michigan Oklahoma Wisconsin Connecticut Alabama South Carolina Mississippi the United States of America Washington Utah Missouri Nebraska

DSKJLVW7X2PROD with BILLS SEC the Federal Food, Drug U.S.C. Health and Human Services Federal CONGRESS Food, Drug Human Services ALS the Food and Drug Adminis- the Public Health Service Act the State of the Union the Food and Drug Administra- Food and Drug Administration Senate Health, Education LATURNER JACOBS KAHELE the Committee on Energy Health VERT HOLT Ms. MATSUI THE HOUSE OF REPRESENTATIVES HHS PUBLIC-PRIVATE PARTNERSHIP House of Representa- LAHOOD the Committee of the Whole House MALLIOTAKIS the Whole House Pensions of the Small Business Act Partnership HARTZLER the Food and Drug Administration the Comptroller General the Department of Health the Food and Drug Admin- RUPPERSBERGER MENAUER FLETCHER MER SCHIFF Drug Administration FUNDS.—A non-Federal

LEVIN KIM GRAVES TORRES JOHNSON SMITH MOORE THOMPSON WILLIAMS CARTER SCHNEIDER WAGNER BEATTY BROWN NORCROSS PANETTA KELLER LURIA JACOBS RUSH BLUNT MAST CARL BROWNLEY ROSS BUTTERFIELD NORTON DEGETTE MENG CARTWRIGHT CLINE BAIRD RASKIN BROOKS TURNER LEGER FERNANDEZ HICE CROW SEWELL VAN SALAZAR LOFGREN MORELLE JACKSON COSTA MANNING ADAMS CRAWFORD STAUBER LEE

expanded access amyotrophic lateral amyotrophic lateral sclerosis sclerosis lateral investigational sep dec dec jkt dec expanded louisiana therapies als florida